AN ULTRASTRUCTURAL ANALYSIS OF TUMOR-PROMOTING PHORBOL DIESTER-INDUCED DEGRANULATION OF HUMAN BASOPHILS

被引:0
|
作者
DVORAK, AM
WARNER, JA
MORGAN, E
KISSELLRAINVILLE, S
LICHTENSTEIN, LM
MACGLASHAN, DW
机构
[1] BETH ISRAEL HOSP,CHARLES & DANA RES INST,BOSTON,MA 02215
[2] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[3] JOHNS HOPKINS UNIV,SCH MED,DIV ALLERGY & CLIN IMMUNOL,BALTIMORE,MD 21205
[4] JOHNS HOPKINS UNIV,SCH MED,JOHNS HOPKINS ASTHMA & ALLERGY CTR,BALTIMORE,MD 21205
来源
AMERICAN JOURNAL OF PATHOLOGY | 1992年 / 141卷 / 06期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Release reactions stimulated in human basophils by a variety of secretogogues show biochemical and morphologic differences as well as similarities. Biochemical differences include those of rate, amount, and order of mediator release, as well as mediator type released or generated.Morphologic diversity of release reactions includes prototypic anaphylactic degranulation (AND), or piecemeal degranulation (PMD), and a continuum of anatomic release comprised of PMD followed by AND that is seen when human basophils are stimulated by the bacterial peptide, formyl methionyl leucyl phenylalanine (FMLP). AND is characterized by extrusion of membrane-free granules through multiple plasma membrane pores; PMD is characterized by partially to comPletely empty, nonfused granule containers in the cytoplasm of basophils. AND is further characterized by diminished-to-absent granules and reduced cytoplasmic vesicles at peak histamine release intervals; PMD does not show decreases in numbers of granules, and cytoplasmic vesicles are plentiful. Smooth membrane-bound vesicles with granule particles and vesicles that appear empty comprise this organelle population PMD is the single most evident activation change present in basophils that traffic into tissues in multiple diseases in vivo. In this study, we examined the ultrastructural kinetic morphology associated with stimulation of human basophils with tetradecanoylphorbol acetate (TPA)-a tumor-promoting phorbol diester known to elicit histamine (but not LTC4) release. Partially purified human basophils were prepared for electron microscopy and examined either after control incubations in buffer alone or at 0 time, 1, 2, 5, 10, 30, and 45 minutes after TPA stimulation. Standard morphology and ultrastructural quantitation of vesicles and granules and contents of vesicles or alteration of granules was done and compared with previous ultrastructural kinetic analyses of human basophil release reactions stimulated by different triggers. Like biochemical studies that have determined that TPA is a unique secretogogue for human basophils, the morphology stimulated by TPA and associated with histamine release was also unique. For example, very minor images of AND were evident Far greater amounts of PMD were imaged PMD was associated with almost-equal-to 50% alteration of cytoplasmic granules by 45 minutes after TPA stimulation. This evidence of empty granules was associated with, and preceded by, a rapid extensive, and sustained increase in particle-containing cytoplasmic vesicles, as compared with buffer controls (P < 0.001 for each TPA stimulation time compared with unstimulated basophils). In addition, previously undescribed interactions of releasing granules and their overlying plasma membranes characterized TPA-stimulated cells. We have termed this a forme fruste of AND and suggest that the previously described additive action of the combined secretogogues (TPA plus anti-IgE) (Schleimer RP et al, J Immunol 1982, 128:136-140) may act by providing a mechanism to convert this forme fruste of AND into fully expressed AND, as defined by morphologic criteria.
引用
收藏
页码:1309 / 1322
页数:14
相关论文
共 50 条
  • [31] EFFECTS OF TUMOR-PROMOTING PHORBOL ESTERS ON CELL AND LYSOSOMAL MEMBRANES
    SIVAK, A
    RAY, F
    VANDUURE.BL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1968, 9 (MAR): : 64 - &
  • [32] EFFECT OF THE ORNITHINE DECARBOXYLASE INHIBITOR DFMO ON PHORBOL DIESTER-INDUCED INHIBITION OF LYMPHOCYTE-B DIFFERENTIATION
    SCHUMAN, LD
    PETRO, TM
    BAXTER, CS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 140 - 140
  • [33] INHIBITION OF STARFISH OOCYTE MATURATION BY TUMOR-PROMOTING PHORBOL ESTERS
    KISHIMOTO, T
    YOSHIKUNI, M
    IKADAI, H
    KANATANI, H
    DEVELOPMENT GROWTH & DIFFERENTIATION, 1985, 27 (03) : 233 - 242
  • [34] DECREASE OF EPIDERMAL HISTIDASE ACTIVITY BY TUMOR-PROMOTING PHORBOL ESTERS
    COLBURN, NH
    LAU, S
    HEAD, R
    CANCER RESEARCH, 1975, 35 (11) : 3154 - 3159
  • [35] PROSTAGLANDINS AS POSSIBLE MEDIATORS OF ACTION OF TUMOR-PROMOTING PHORBOL ESTERS
    LAU, S
    COLBURN, N
    CLINICAL RESEARCH, 1975, 23 (04): : A558 - A558
  • [36] REGULATION OF CARDIAC MYOCYTE HYPERTROPHY BY A TUMOR-PROMOTING PHORBOL ESTER
    SIMPSON, PC
    KARLINER, JS
    CLINICAL RESEARCH, 1985, 33 (02): : A229 - A229
  • [37] RECEPTORS FOR TUMOR-PROMOTING PHORBOL ESTERS IN RAT VENTRAL PROSTATE
    CARMENA, MJ
    GARCIAPARAMIO, MP
    PRIETO, JC
    CANCER LETTERS, 1993, 68 (2-3) : 143 - 147
  • [38] TUMOR-PROMOTING PHORBOL ESTERS AND MEZEREIN INDUCE CONTRACTION IN HYDRA
    SHIBA, Y
    EXPERIENTIA, 1982, 38 (04): : 498 - 499
  • [39] DIFFERENT TRANSLOCATION OF 3 DISTINCT PKC ISOFORMS WITH TUMOR-PROMOTING PHORBOL ESTER IN HUMAN PLATELETS
    CRABOS, M
    IMBER, R
    WOODTLI, T
    FABBRO, D
    ERNE, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (03) : 878 - 883
  • [40] AGGREGATION OF HUMAN-LYMPHOBLASTOID CELLS BY TUMOR-PROMOTING PHORBOL ESTERS AND DIHYDROTELEOCIDIN-B
    HOSHINO, HO
    MIWA, M
    FUJIKI, H
    SUGIMURA, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 95 (02) : 842 - 848